| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Credo Advanced Chemicals Limited |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Non-current assets |
|
|
|
Property, plant and equipment |
43,254.45 |
41,517.79 |
|
Other Intangible Assets |
261.43 |
277.19 |
|
Rights of use Assets |
2,257.73 |
2,818.12 |
|
Capital work-in-progress |
5,662.28 |
4,250.63 |
|
Non-current assets held for sale |
300.82 |
300.82 |
|
Other financial assets |
0.47 |
0.45 |
|
Other Non-Current Assets |
145.34 |
377.50 |
|
Current assets |
|
|
|
Inventories |
7,593.72 |
8,991.77 |
|
Trade receivables |
2,152.64 |
2,163.20 |
|
Cash and cash equivalents |
737.12 |
28.74 |
|
Other Bank Balances |
487.13 |
408.98 |
|
Current Tax assets |
15.60 |
12.83 |
|
Other current assets |
794.24 |
899.66 |
|
Total Assets |
63,662.99 |
62,047.69 |
|
Equity |
|
|
|
Equity share capital |
7,500.00 |
7,500.00 |
|
Other equity |
22,451.57 |
17,461.96 |
|
Non controlling interest |
988.60 |
1,598.69 |
|
Non-current liabilities |
|
|
|
Borrowings |
17,711.24 |
20,151.42 |
|
Lease Liabilities |
1,585.76 |
1,954.99 |
|
Other Non- Current Liabilities |
389.67 |
605.81 |
|
Provisions |
77.21 |
53.59 |
|
Deferred Tax Liabilities (Net) |
2,435.16 |
1,287.22 |
|
Current Liabilities |
|
|
|
Trade Payables |
4,615.87 |
4,018.48 |
|
Borrowings |
2,599.45 |
4,030.51 |
|
Lease Liabilities |
174.30 |
169.37 |
|
Other Financial Liabilities |
- |
- |
|
Provisions |
415.35 |
233.85 |
|
Other current liabilities |
2,721.55 |
2,935.34 |
|
Current Tax Liabilities |
(1.74) |
46.47 |
|
Total Equity and Liabilities |
63,662.99 |
62,047.69 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Income |
|
|
|
Revenue from operations |
27,866.91 |
22,279.35 |
|
Other income |
65.28 |
43.58 |
|
Total Income |
27,932.19 |
22,322.93 |
|
Expenses |
|
|
|
Cost of Material Consumed |
8,264.02 |
9,333.83 |
|
Changes in Inventory of finished goods, work in progress and stores and spares |
919.52 |
(291.33) |
|
Purchase of stock-in-trade |
2,228.06 |
- |
|
Employee benefits expenses |
1,942.27 |
1,435.29 |
|
Finance costs |
2,608.85 |
2,721.83 |
|
Depreciation and amortization
expenses |
1,699.95 |
1,844.86 |
|
Other expenses |
6,121.67 |
4,571.72 |
|
Total Expenses |
23,784.34 |
19,616.20 |
|
Profit/(Loss) before tax |
4,147.85 |
2,706.73 |
|
Current Tax |
11.17 |
125.43 |
|
Deferred Tax |
1,212.65 |
840.91 |
|
MAT credit entitlement |
(3.92) |
- |
|
Profit/ (loss) after tax for the
period |
5,353.25 |
1,7.40.39 |
|
Other comprehensive income |
|
|
|
Items that will be reclassified to
profit or loss: |
238.30 |
212.73 |
|
Income tax relating to these items |
(59.58) |
(53.18) |
|
Item that will be not be
classified to profit or loss |
|
|
|
Remeasurement of post-employment
benefit obligations |
2.81 |
(7.90) |
|
Income Tax relating to these items |
3.13 |
(4.81) |
|
Actuarial gains and losses |
(4.05) |
0.80 |
|
Total Other
comprehensive income for
the period, net of tax |
180.62 |
157.25 |
|
Total Comprehensive Income for the
Period |
5,533.86 |
1,897.64 |
|
Earnings Per Share (Rs.): |
|
|
|
Basic |
7.14 |
2.32 |
|
Diluted |
7.14 |
2.32 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Cash Flow From Operating
Activities |
|
|
|
Net Profit before tax and
extraordinary items |
4,147.85 |
2,706.73 |
|
Adjustments for non Cash/ Non
trade items: |
|
|
|
Depreciation & Amortization
Expenses |
16,99.95 |
1,844.86 |
|
Interest expenses |
3,145.62 |
2,721.83 |
|
Deferred tax |
- |
889.29 |
|
Interest Income |
(58.32) |
(21.52) |
|
Operating profits before Working
Capital Changes |
8,935.11 |
8,141.19 |
|
Adjusted For: |
|
|
|
(Increase) / Decrease in trade
receivables |
10.55 |
(378.75) |
|
Increase / (Decrease) in trade
payables |
597.39 |
(411.76) |
|
(Increase) / Decrease in
inventories |
1,398.05 |
(195.79) |
|
Increase / (Decrease) in other
current liabilities |
(213.79) |
922.82 |
|
Other Current financial Liability |
|
|
|
(Increase) / Decrease in other
current assets |
105.42 |
(296.82) |
|
Increase / (Decrease) in Short
term Provision |
181.50 |
25.36 |
|
Increase / (Decrease) in Current
tax liabilities(net) |
(26.39) |
71.69 |
|
Increase / (Decrease) in Long term
Provision |
23.63 |
20.25 |
|
Cash generated from Operations |
11,011.46 |
7,898.19 |
|
Income Tax (Paid) / Refund |
(24.59) |
(23.09) |
|
Net Cash flow from Operating
Activities |
10,986.87 |
7,875.10 |
|
Cash Flow From Investing
Activities |
|
|
|
Purchase/ Sale of tangible assets |
(3,436.61) |
(4,746.33) |
|
(Increase)/ Decrease in Capital
WIP |
(1,411.65) |
4,787.26 |
|
Purchase/ Sale of intangible
assets |
15.77 |
15.77 |
|
(Increase) Decrease of right of
use assets |
560.39 |
- |
|
Current investments / (Purchased)
sold |
- |
178.34 |
|
Interest Received |
- |
21.52 |
|
Other Non Current financial
Liability |
1,147.94 |
(619.95) |
|
Lease liabilities |
(364.29) |
(65.79) |
|
(Increase) / Decrease in other
non-current assets |
232.15 |
(251.04) |
|
Other Non-current financial assets |
(0.02) |
(0.02) |
|
Change in deposits |
(78.15) |
392.27 |
|
Net Cash used in Investing
Activities |
(3,334.48) |
(287.98) |
|
Cash Flow From Financing
Activities |
|
|
|
Finance Cost |
(3,087.31) |
(2,721.83) |
|
Increase/ (Decrease) in Minority
Interest |
(610.09) |
432.40 |
|
Changes In other Equity |
841.77 |
(2,943.39) |
|
Other non-current liabilities |
(216.15) |
- |
|
Increase in / (Repayment) of Short
term Borrowings |
(1,431.06) |
(592.20) |
|
Increase in / (Repayment) of Long
term borrowings |
(2,440.18) |
(4,250.18) |
|
Net Cash used in Financing
Activities |
(6,944.01) |
(10,075.21) |
|
Net Increase/(Decrease) in Cash
& Cash Equivalents |
708.38 |
(2,488.08) |
|
Cash & Cash Equivalents at
Beginning of period |
28.74 |
2,516.82 |
|
Cash & Cash Equivalents at End
of period |
737.12 |
28.74 |
Summary of the Cash Flow Statement for the years 2025 and 2024:
In
FY 2025, the company earned a net profit before tax and extraordinary items of ₹4,147.85 lakhs,
higher than ₹2,706.73
lakhs in FY 2024. After adding back non-cash charges like
depreciation (₹1,699.95
lakhs) and interest expenses (₹3,145.62 lakhs), and adjusting for
deferred tax and interest income, the operating
profit before working capital changes stood at ₹8,935.11 lakhs
versus ₹8,141.19 lakhs
in FY 2024. Working capital movements also supported cash flow – inventories
reduced (₹1,398.05
lakhs), trade payables increased (₹597.39 lakhs) and
receivables decreased slightly (₹10.55
lakhs). Some pressure came from a fall in other current
liabilities (₹213.79
lakhs). Finally, after a small tax outflow of ₹24.59 lakhs, the
company generated a strong net
operating cash inflow of ₹10,986.87 lakhs in FY 2025, much
better than the ₹7,875.10
lakhs generated in FY 2024.
During
FY 2025, the company spent on buying tangible assets (₹3,436.61 lakhs) and
capital work-in-progress (₹1,411.65
lakhs). However, it also got some positive inflows from
reduction in right-of-use assets (₹560.39
lakhs) and recognition of non-current financial liabilities (₹1,147.94 lakhs).
Other smaller inflows came from deposits and adjustments in non-current assets.
As a result, the company had a net
inflow of ₹3,334.48 lakhs from investing activities in FY 2025,
compared to a smaller inflow of ₹287.98
lakhs in FY 2024.
Financing
activities remained negative in FY 2025. The company paid a high finance cost
of ₹3,087.31 lakhs
and reduced borrowings — short-term borrowings fell by ₹1,431.06 lakhs and
long-term borrowings by ₹2,440.18
lakhs. Minority interest also decreased (₹610.09 lakhs). On
the positive side, there was a rise in equity reserves (₹841.77 lakhs).
Altogether, financing activities resulted in a net outflow of ₹6,944.01 lakhs in FY
2025, which was better than the larger outflow of ₹10,075.21 lakhs in
FY 2024.
After
combining all three activities, the company recorded a net increase in cash of ₹708.38 lakhs
in FY 2025. In contrast, FY 2024 had seen a net decrease of ₹2,488.08 lakhs. The
closing balance of cash and cash equivalents improved significantly to ₹737.12 lakhs in FY
2025, compared to only ₹28.74
lakhs at the end of FY 2024.
|
Particulars |
2025 |
2024 |
|
Current
Ratio |
1.56 |
1.52 |
|
Debt-Equity
Ratio |
0.08 |
0.08 |
|
Debt service
coverage ratio |
1.62% |
1.07% |
|
Trade
Receivables Turnover Ratio |
11.83 |
0.00 |
|
Net Capital
Turnover Ratio |
27.87% |
28.58% |
|
Net Profit
ratio |
5.88% |
3.69% |
|
Return on
Capital Employed Ratio |
0.62% |
0.61% |
|
Return on
Investment |
1.66% |
1.23% |
Summary of
the financial ratios of Credo Advanced Chemicals Limited for
the year 2024 & 2025:
2025:
1.56 | 2024: 1.52
The current ratio shows how well the company can pay its short-term liabilities
with its short-term assets. A ratio above 1 means it has more assets than
liabilities. The ratio improved slightly in 2025, which means the company’s
short-term liquidity position became a little stronger compared to last year.
2025:
0.08 | 2024: 0.08
This ratio shows how much debt the company has compared to its equity. A very
low ratio like 0.08 indicates the company relies very little on debt and mostly
on its own equity. There is no change from last year, meaning the company
continues to have a very safe capital structure with very low financial risk.
025:
1.62% | 2024: 1.07%
The DSCR shows how easily the company can pay interest and debt obligations
from its earnings. A higher number is better. In 2025, the DSCR improved to
1.62% from 1.07%, meaning the company is in a stronger position to service its
debt compared to last year.
2025:
11.83 | 2024: 0
This ratio shows how many times the company collects its receivables during the
year. A big jump to 11.83 in 2025 means the company is collecting payments from
customers much faster and managing credit sales very efficiently compared to
last year, where it was zero (very poor).
2025:
27.87% | 2024: 28.58%
This ratio shows how effectively the company uses its working capital to
generate revenue. The ratio fell slightly in 2025, from 28.58% to 27.87%, which
means efficiency reduced a little. Still, the ratio is quite healthy.
2025:
5.88% | 2024: 3.69%
this ratio shows how much profit the company makes from its sales. The
improvement from 3.69% to 5.88% means the company is now earning more profit on
each rupee of sales, showing stronger profitability in 2025.
2025:
0.62% | 2024: 0.61%
ROCE shows how well the company uses its total capital (equity + debt) to
generate profit. The ratio improved very slightly from 0.61% to 0.62%, meaning
capital efficiency remained almost the same, with just a minor improvement.
2025:
1.66% | 2024: 1.23%
ROI shows how much return the company is generating on its investments. An
increase to 1.66% in 2025 from 1.23% in 2024 means the company’s investments
are giving better returns than last year.